Int J Med Sci 2019; 16(10):1350-1355. doi:10.7150/ijms.33277 This issue Cite

Research Paper

Comparison of adhesion prevention capabilities of the modified starch powder-based medical devices 4DryField® PH and Arista™ AH in the Optimized Peritoneal Adhesion Model

Daniel Poehnert1 Corresponding address*, Lavinia Neubert2*, Juergen Klempnauer1, Paul Borchert2, Danny Jonigk2, Markus Winny1

1. Department of General, Visceral and Transplantation Surgery, Hannover Medical School, Hannover, Germany
2. Institute of Pathology, Hannover Medical School, Hannover, Germany
* These authors contributed equally

Poehnert D, Neubert L, Klempnauer J, Borchert P, Jonigk D, Winny M. Comparison of adhesion prevention capabilities of the modified starch powder-based medical devices 4DryField® PH and Arista™ AH in the Optimized Peritoneal Adhesion Model. Int J Med Sci 2019; 16(10):1350-1355. doi:10.7150/ijms.33277.
Other styles

File import instruction


Adhesion barriers can be based on numerous substances. In the rat Optimized Peritoneal Adhesion Model (OPAM) the starch-based hemostats 4DryField and Arista were tested for their capability to act in a preventive manner against adhesion formation (applied as a powder that was mixed in situ with saline solution to form a barrier gel). Adhesions were scored using the established scoring systems by Lauder and Hoffmann, as well as histopathologically using the score by Zühlke. Animals receiving saline solution were used as controls. As previously published, 4DryField reduced peritoneal adhesions significantly. However, Arista did not lead to a statistically significant reduction of adhesion formation. When comparing 4DryField and Arista applied in the same manner, only 4DryField was significantly effective in preventing peritoneal adhesions. Histopathological evaluations confirmed the results of the macroscopic investigation, leading to the conclusion that starch-based hemostats do not generally have the capability to function as effective adhesion prevention devices.

Keywords: Adhesion prevention, abdominal surgery, rat model OPAM, 4DryField® PH, AristaTM AH


Surgery is the most common cause for formation of peritoneal adhesions. Predisposing factors include mechanical injury of the peritoneum and local ischemia due to manipulation and retraction of abdominal tissues during surgery [1-4]. The incidence of postoperative adhesion formation ranges from 67 to 93% [5]. Several adhesion prevention barrier agents addressing this problem are available on the market. In the majority of cases these agents function as a physical barrier to separate wound areas at risk of developing adhesions. These devices include adhesion barriers made from oxidized regenerative cellulose [6], polytetrafluoroethylene [7], icodextrin [8], hyaluronic acid/carboxymethyl cellulose [9] and starch [10]. Typically, starch-based products are used solely as hemostats, such as Arista™ AH (Arista; Davol Inc., USA) [11]. A unique starch-based medical device is 4DryField® PH (4DryField; PlantTec Medical GmbH, Germany) as it is the only product proven to provide hemostasis and prevent the formation of adhesions. While 4DryField is applied as a powder for hemostasis, the powder is transformed into a gel by mixing with saline solution for adhesion prevention.

This raised the question if modified starch powders other than 4DryField might also be capable of reducing adhesion formation when applied in the same way as 4DryField. Previously, Hoffmann et al. [12] found Arista to be moderately effective in preventing adhesions, whereas no effect was observed in a study by Singh et al. [13]. Therefore, the aim of the present study was to test 4DryField and Arista for their capability in preventing postoperative peritoneal adhesion formation in a challenging and well-reproducible rat model, the recently described Optimized Peritoneal Adhesion Model (OPAM) [14]. This model has been shown to induce severest adhesions with high reliability and it has already been utilized successfully to examine the effectiveness of 4DryField compared to a control group [15], as well as in a comparative study with 4DryField and other adhesion prevention devices based on different materials [16]. The model includes abrasion of the cecum and incision of the abdominal wall, as well as meso-stitch approximation of these lesions.

Materials and Methods


Thirty-six male Lewis rats were included in the study. They were housed under standard conditions, had access to fresh water at any time and were fed a standard diet ad libitum. Prior to and after surgery, daily monitoring of body weight and behavioral changes assessed animal welfare. Animal experiments were performed at the central animal laboratory of the Hanover Medical School, Germany, as well as the therapeutic experimental unit, Faculty of Medicine, Nantes, France. All protocols regarding animal life quality were conducted in accordance with national and European regulations. The present study was approved by The Lower Saxony State Office for Consumer Protection and Food Safety (LAVES Hannover, Germany; approval code 12/0751) and the Ethical Committee For Animal Experiments (CEEA) in Pays de la Loire, France (approved under the reference APAFIS9771).

Surgical procedures and application of anti-adhesive agents

General anesthesia was achieved by ketamine (80 mg/kg body weight) and xylazine (5 mg/kg body weight) or inhalation of isoflurane 3%. The required level of narcosis was reached when the flexor reflexes were suppressed. A 3 cm long median laparotomy was performed after shaving and sanitizing the abdomen. Adhesion induction was carried out according to the OPAM [14]: 1) the cecum was delivered and kept moist with a watery gauze swab, the cecal peritoneum was gently abraded repeatedly over a 1x2 cm area in a standard manner using a dry gauze until removal of visceral peritoneum resulted in sub-serosal bleeding and the creation of a homogenous surface of petechial hemorrhages; 2) the parietal peritoneum and inner muscle layer were sharply dissected in order to create a 1x2 cm abdominal wall defect; 3) both injured areas were approximated using a non-absorbable suture. Prior to surgery, animals were randomly assigned to one of the following three groups: control (n=10), 4DryField-treated (n=16) or Arista-treated (n=10, carried out in France). Control animals received 1.2 ml 0.9% sterile saline solution intraperitoneally. The two anti-adhesive agents 4DryField and Arista were each administered in a total amount of 300 mg powder/animal. The powder was evenly distributed on the two defects and then transformed into a gel by dripping with 1.2 ml sterile 0.9% saline solution before the approximating suture was placed. The abdomen was closed using a two-layer closure technique by consecutive sutures. Following surgery, the animals were monitored until they were completely awakened and kept warm using an infrared lamp. Animals received novaminsulfone or buprenorphine in a body-weight adapted dose to minimize postoperative pain. On postoperative day 7, the animals were sacrificed using CO2 narcosis followed by cervical disclosure. The peritoneal cavity was opened by an incision at a left-sided position remote to the original laparotomy scar to prevent damaging any potentially formed adhesions. Specimens of cecum, abdominal wall and adhesions were harvested for histopathological assessment.

A detailed protocol was generated and provided to the surgeons in France to ensure uniformity of execution and, thereby, comparability of the results. Apart from step-by-step descriptions of the procedures, photographs illustrated all steps in detail, particularly the abrasion of the cecum, the dissection of peritoneum and inner muscle layer, as well as the application of the adhesion barrier.

Adhesion assessment

The adhesion formation between the defective abdominal wall and cecum was evaluated macroscopically by two independent observers according to the scoring systems by Lauder et al. [17] and Hoffmann et al. [12]. The Lauder scoring system (Table 1) takes into account number, strength and distribution of adhesions in a single score, while the Hoffmann scoring system (Table 2) consists of three individual scores for area, extent and strength of adhesions that are summed up to yield a total score.

 Table 1 

Adhesion scoring system according to Lauder et al. [17]

0No adhesions
1Thin filmy adhesions
2More than one thin adhesion
3Thick adhesion with focal point
4Thick adhesion with planar attachment
5Very thick vascularized adhesions or more than one planar adhesion
 Table 2 

Adhesion scoring system according to Hoffmann et al. [12]

Area score
0No adhesion
1Cecum to bowel adhesion
2Cecum to sidewall adhesion over less than 25% of the abraded surface area
3Cecum to sidewall adhesion between 25 and 50% of the abraded surface area
4Cecum to sidewall adhesion over more than 50% of the surface area
Strength score
0No adhesion
1Gentle traction required to break adhesion
2Blunt dissection required to break adhesion
3Sharp dissection required to break adhesion
Extent score
0No adhesion
1Filmy adhesion
2Vascularized adhesion
3Opaque or cohesive adhesion


Surgical specimens were fixed in buffered 4% formaldehyde solution. After dehydration and paraffin embedding, serial thin sections of 1-2 μm were mounted on glass slides, stained with standard Hematoxylin and Eosin (HE), Elastika-van-Gieson (EvG) and periodic acid-Schiff (PAS) staining (Sigma Aldrich Co Ltd, USA) and light microscope examinations were performed by experienced pathologists.

The quantitative analysis of the histologic stainings was performed using Zühlke's microscopic adhesion classification. This system has already been established for grading of peritoneal adhesions induced with models very similar to OPAM [19, 20].

Statistical analyses

Adhesion scores are presented as arithmetic means with standard deviations (SD). Since most of the data sets did not follow a Gaussian distribution (as determined using the D'Agostino-Pearson normality test) the multiple comparisons of adhesion scores of the three groups were performed using Kruskal-Wallis test followed by Dunn's multiple comparisons test for non-parametric data (which utilizes correction for multiple comparison by statistical hypothesis testing). Groups were defined to be significantly different if p<0.05. Statistical analyses were performed using GraphPad Prism (Version 7.0b for Mac OS, GraphPad Software, Inc., La Jolly, USA).


All animals showed comparable viability and body weight development. None of the animals had to be sacrificed prematurely due to complications; all 36 animals completed the study.

Adhesion development

In the control group, 9 of 10 animals showed peritoneal adhesions, which were rated with the maximum Lauder score, as well as the maximum scores regarding all of the Hoffmann categories (Figure 1A,B). None of the sixteen 4DryField-treated animals developed any adhesions (Figure 1C,D). In contrast, all 10 Arista-treated animals developed peritoneal adhesions (Figure 1E,F). Two developed filmy adhesions, with a Lauder score of 1 each. The total Hoffmann scores of these two animals differed and were 3 and 7, respectively. The other eight Arista-treated animals developed severe adhesions with Lauder scores of 4 (n=6) or 5 (n=2) and total Hoffmann scores of 8 (n=4), 9 (n=3) or 10 (n=1). The mean score value of each group was calculated and tested for significant differences (Table 3). Herein, 4DryField PH reduced the incidence and severity of peritoneal adhesion formation significantly compared to the control, as well as to the Arista-treatment group and concerning every evaluated scoring system. In contrast, Arista-treatment did not lead to a statistically significant reduction of adhesion formation in comparison to control animals.

 Table 3 

Microscopic adhesion classification according to Zühlke et al. [18]

0No adhesions
1Weak connective tissue, rich cell, new and old fibrin, thin reticulin fibrils
2Connective tissue which has cells and capillaries. few collagen fibers
3Thicker connective tissue. Few cells and elastic and smooth muscle fibers, more vessels
4Old and thick granulation tissue, poor cells, difficult separation of serosal surfaces

Histological Evaluation

Figure 2 shows representative PAS-stained tissue slides from all three groups. Figure 2A shows a control animal where the smooth muscle layers of the cecum (top) are fused to skeletal muscles of the abdominal wall (bottom) via dense granulating tissue. The histological findings support the macroscopic observation that both, cecum and abdominal wall, could not readily be separated by mechanical force. Figure 2B shows cecal and Figure 2C abdominal wall tissue of an animal from the 4DryField group.

 Figure 1 

Representative photographs of the pathological evaluation of control (A,B), 4DryField- (C,D) and Arista-treated (E,F) rats on day 7.

Int J Med Sci Image

(View in new window)

In contrast to 9 of the 10 control animals, no agglutinations occurred in the 4DryField group. Furthermore, in all animals of the 4DryField group the lesions of the cecum and the abdominal wall defect had healed, and both featured neomesothelial cell coverage. The former abdominal wall defect was filled with fibrous tissue, which still contained slight remnants of 4DryField particles. Figure 2D shows an animal from the Arista group. As in Figure 2A the smooth muscles of the cecum (top) were fused to the skeletal muscles of the abdominal wall (bottom) via dense granulation tissue, preventing separation of cecum and abdominal wall by mechanical force.

The microscopic classification of the adhesions according to Zühlke et al. [18] was performed all animals. In the control group one animal was scored 0, two were scored 3 and seven were scored 4, in the 4DryField group the microscopic assessment was equivalent to the macroscopic investigation with all 16 animals being scored 0. In the Arista group one animal was scored 1, one was scored 2, four were scored 3, and four were scored 4.

Like for the macroscopic adhesion assessment the mean scores were calculated and tested for significant differences (Table 5). The results were conform with the macroscopic assessment, the 4DryField treated animals scored significantly better results than the Arista treated ones as well as the control animals, while the Arista group did not show statistically significant differences to the control.


As shown in previous studies [14-16], the OPAM consistently induced severe peritoneal adhesions after cecal abrasion and creation of abdominal wall defects in rats.

4DryField revealed excellent adhesion prevention capabilities, completely preventing the formation of any adhesions. Furthermore, a newly-formed mesothelial layer was found by histopathological assessments of the previously injured sides. 4DryField could be shown to be highly effective in preventing peritoneal adhesions in previous studies, being prophylactically applied either as a preformed gel or as powder that was transformed in situ into a gel by adding saline solution [15, 16].

 Table 4 

Arithmetic mean values (AM), standard deviations (SD) and p-values in comparison to the control (p (ctrl)) or 4DryField (p (4DF)) groups (statistically significant difference if p<0.05, *)

ScoreGroupAMSDp (ctrl)p (4DF)
Hoffmann Area4DryField0.00.0<0.0001*
Hoffmann Strength4DryField0.00.0<0.0001*
Hoffmann Extent4DryField0.00.0<0.0001*
Hoffmann Total4DryField0.00.0<0.0001*
 Table 5 

Arithmetic mean values (AM), standard deviations (SD) and p-values in comparison to the control (p (ctrl)) or 4DryField (p (4DF)) groups (statistically significant difference with p<0.05, *)

ScoreGroupAMSDp (ctrl)p (4DF)
 Figure 2 

Representative histological slides (PAS-stained) of animals from the control (A), 4DryField (B, C) and Arista (D) groups. Black arrows indicate neomesothelial coverage.

Int J Med Sci Image

(View in new window)

The adhesion prevention capabilities of Arista were examined for the first time in 2009 by Hoffmann et al. [12]. Although the authors found the adhesion development to be significantly reduced in comparison to a control group, the adhesion reduction was still limited with an adhesion score of 3.9 (Arista) vs. 6.0 (control). In 2013, Singh et al. challenged these results in a randomized-controlled trial using Arista in a rat model with adhesion induction at the cecum and the uterine horn. Adhesion prevention capabilities of Arista were found to be not different from those of the control group, which received Ringer's lactate solution [13].

In our present study, Arista did not lead to a statistically significant reduction of adhesion formation compared to control animals using Lauder and Hoffmann scoring systems, as well as systematic histopathological examinations using the Zühlke microscopic classification system and confirming the macroscopic results. The microscopic analysis showed tight agglutinations of cecum and abdominal wall via granulating tissue, comparable to those of the control animals. When comparing 4DryField and Arista applied in the same manner, 4DryField resulted in a significantly more effective reduction of adhesion scores.

Limited comparability of the results arising from differing surgical performance at the two study centers can be excluded due to strict monitoring of the comparability as described above. Additionally, the OPAM has been used at the Hanover Medical School extensively [14-16] and different surgeons have performed surgeries following this protocol in the past, but a correlation of results with the respective surgeon has never been observed. Correspondingly, the model has been shown to be highly reliable and very robust.

In summary, in this experimental animal model of severe peritoneal adhesion induction only 4DryField but not Arista was effective in reducing postoperative adhesion formation when both devices were applied in the same manner. Our results show that modified starch-based powder hemostats are not naturally capable to reduce the formation of peritoneal adhesions. Instead, the effectiveness depends on the specific properties of the individual product, which are often not reported in detail and might be of interest for further investigations.


The authors would like to thank Dres. Valérie Dumay and Pierre Layrolle for generous sharing of data obtained in the Therapeutic Experimental Unit, Faculty of Medicine, Nantes, France. They performed the Arista experiments, funded by PlantTec Medical GmbH, Germany. The authors are also grateful to Valentina Osmani for editing the manuscript.

Competing Interests

The authors have declared that no competing interest exists.


1. Ellis H. The clinical significance of adhesions: focus on intestinal obstruction. Eur J Surg Suppl. 1997:5-9

2. Lehmann-Willenbrock EL, Mecke H, Riedel HH. Sequelae of Appendectomy, with Special Reference to Intra-Abdominal Adhesions, Chronic Abdominal Pain, and Infertility. Gynecologic and Obstetric Investigation. 1990;29:241-5

3. Luijendijk RW, de Lange DC, Wauters CC. et al. Foreign material in postoperative adhesions. Ann Surg. 1996;223:242-8

4. Menzies D. Postoperative Adhesions - their Treatment and Relevance in Clinical Practice. Ann R Coll Surg Engl. 1993;75:147-53

5. Beyene RT, Kavalukas SL, Barbul A. Intra-abdominal adhesions: Anatomy, physiology, pathophysiology, and treatment. Curr Probl Surg. 2015;52:271-319

6. Sawada T, Nishizawa H, Nishio E, Kadowaki M. Postoperative adhesion prevention with an oxidized regenerated cellulose adhesion barrier in infertile women. J Reprod Med. 2000;45:387-9

7. Group TMAMS. An expanded polytetrafluoroethylene barrier (Gore-Tex Surgical Membrane) reduces post-myomectomy adhesion formation. The Myomectomy Adhesion Multicenter Study Group. Fertil Steril. 1995;63:491-3

8. Sakari T, Sjodahl R, Pahlman L, Karlbom U. Role of icodextrin in the prevention of small bowel obstruction. Safety randomized patients control of the first 300 in the ADEPT trial. Colorectal Dis. 2016;18:295-300

9. Joung JY, Ha YS, Singer EA. et al. Use of a hyaluronic acid-carboxymethylcellulose adhesion barrier on the neurovascular bundle and prostatic bed to facilitate earlier recovery of erectile function after robot-assisted prostatectomy: an initial experience. J Endourol. 2013;27:1230-5

10. Korell M, Ziegler N, De Wilde RL. Use of Modified Polysaccharide 4DryField® PH for Adhesion Prevention and Hemostasis in Gynecological Surgery: A Two-Center Observational Study by Second-Look Laparoscopy. Biomed Res Int. 2016;2016:1-9

11. Bruckner BA, Blau LN, Rodriguez L. et al. Microporous polysaccharide hemosphere absorbable hemostat use in cardiothoracic surgical procedures. Journal of Cardiothoracic Surgery. 2014:9

12. Hoffmann NE, Siddiqui SA, Agarwal S. et al. Choice of hemostatic agent influences adhesion formation in a rat cecal adhesion model. J Surg Res. 2009;155:77-81

13. Singh P, Vasques D, Deleon F. Microporous Polysaccharide Hemospheres for Adhesion Prevention: A Randomized Controlled Trial. Journal of Gynecologic Surgery. 2013;29:196-202

14. Poehnert D, Abbas M, Kreipe H-H, Klempnauer J, Winny M. High reproducibility of adhesion formation in rat with meso-stitch approximation of injured cecum and abdominal wall. Int J Med Sci. 2015;12:1-6

15. Poehnert D, Abbas M, Kreipe H-H, Klempnauer J, Winny M. Evaluation of 4DryField® PH as Adhesion Prevention Barrier Tested in an Optimized Adhesion Model (OPAM) in Rats. Eur Surg Res. 2015;55:341-51

16. Poehnert D, Grethe L, Maegel L. et al. Evaluation of the Effectiveness of Peritoneal Adhesion Prevention Devices in a Rat Model. Int J Med Sci. 2016;13:524-32

17. Lauder CI, Garcea G, Strickland A, Maddern GJ. Use of a modified chitosan-dextran gel to prevent peritoneal adhesions in a rat model. J Surg Res. 2011;171:877-82

18. Zühlke HV, Lorenz EMP, Straub EM, Savvas V. Pathophysiologie und Klassifikation von Adhäsionen. 1990;:1009-16.

19. Karaca G, Aydin O, Pehlivanli F. et al. Effect of ankaferd blood stopper in experimental peritoneal adhesion model. Ann Surg Treat Res. 2016;90:213-7

20. Gokcelli U, Ercan UK, Ilhan E, Argon A, Cukur E, Ureyen O. Prevention of Peritoneal Adhesions by Non-Thermal Dielectric Barrier Discharge Plasma Treatment on Mouse Model: A Proof of Concept Study. J Invest Surg. 2019:1-10

Author contact

Corresponding address Corresponding author: Dr. Daniel Poehnert, PhD. Carl-Neuberg-Strasse 1, D-30625 Hannover (Germany); Tel. +49 511 5326534; Fax +49 511 5324010; E-Mail poehnert.danielde

Received 2019-1-18
Accepted 2019-7-22
Published 2019-9-19

Citation styles

Poehnert, D., Neubert, L., Klempnauer, J., Borchert, P., Jonigk, D., Winny, M. (2019). Comparison of adhesion prevention capabilities of the modified starch powder-based medical devices 4DryField® PH and Arista™ AH in the Optimized Peritoneal Adhesion Model. International Journal of Medical Sciences, 16(10), 1350-1355.

Poehnert, D.; Neubert, L.; Klempnauer, J.; Borchert, P.; Jonigk, D.; Winny, M. Comparison of adhesion prevention capabilities of the modified starch powder-based medical devices 4DryField® PH and Arista™ AH in the Optimized Peritoneal Adhesion Model. Int. J. Med. Sci. 2019, 16 (10), 1350-1355. DOI: 10.7150/ijms.33277.

Poehnert D, Neubert L, Klempnauer J, Borchert P, Jonigk D, Winny M. Comparison of adhesion prevention capabilities of the modified starch powder-based medical devices 4DryField® PH and Arista™ AH in the Optimized Peritoneal Adhesion Model. Int J Med Sci 2019; 16(10):1350-1355. doi:10.7150/ijms.33277.

Poehnert D, Neubert L, Klempnauer J, Borchert P, Jonigk D, Winny M. 2019. Comparison of adhesion prevention capabilities of the modified starch powder-based medical devices 4DryField® PH and Arista™ AH in the Optimized Peritoneal Adhesion Model. Int J Med Sci. 16(10):1350-1355.

This is an open access article distributed under the terms of the Creative Commons Attribution License ( See for full terms and conditions.